Citation 19491

ISHIZUKA,M: MASUDA,T: KANBAYASHI,N: WATANABE,Y: MATSUZAKI,M: SAWAZAKI,Y: OHKURA,A: TAKEUCHI,T: UMEZAWA,H:. (1982). ANTITUMOR EFFECT OF FORPHENICINOL, A LOW MOLECULAR WEIGHT IMMUNOMODIFIER, ON MURINE TRANSPLANTABLE TUMORS AND MICROBIAL INFECTIONS.. 35(8)

Citation Details

TitleANTITUMOR EFFECT OF FORPHENICINOL, A LOW MOLECULAR WEIGHT IMMUNOMODIFIER, ON MURINE TRANSPLANTABLE TUMORS AND MICROBIAL INFECTIONS.
AuthorsISHIZUKA,M: MASUDA,T: KANBAYASHI,N: WATANABE,Y: MATSUZAKI,M: SAWAZAKI,Y: OHKURA,A: TAKEUCHI,T: UMEZAWA,H:
Year1982
Volume35
Issue8

Summary

Year: 1982

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
2
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
3
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
4
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
5
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
6
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
7
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
8
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
9
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
10
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
11
TOXICITY ASSESSMENT(QUANTITATIVE)
TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO
FORPHENICINOL
.
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
INACTIVE
13
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
None
14
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
INACTIVE
15
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
INACTIVE
16
ANTITUMOR ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
ACTIVE
17
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
ACTIVE
18
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
ACTIVE
19
ANTITUMOR ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
ACTIVE
20
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
INACTIVE
21
ANTITUMOR ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FORPHENICINOL
ACTIVE
22
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
FORPHENICINOL
ACTIVE
Show SPARQL Queries (1)